Companies: 10,795·Total market cap: $144.5T
AbCellera Biologics Inc.

AbCellera Biologics Inc.

ABCLNASDAQHealthcare● Active
$5.56
$-0.06(-1.11%)
Market Cap$1.7B
P/E Ratio
52W High$6.79
52W Low$2.33
Overview

AbCellera Biologics Inc. (ABCL) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ABCL · as of Feb 24, 2026

Latest filing snapshot

562
-38-6.33%vs prior year

AbCellera Biologics Inc. (ABCL) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
562
Change (1Y)
-38
Growth % (1Y)
-6.33%
Revenue / Employee
$133.7K
Net Income / Employee
$-260.5K
Market Cap
$1.7B

ABCL Employee Count

2020 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-02-24562-38-6.33%
2025-02-27600+14+2.39%
2024-02-20586+91+18.38%
2023-02-21495+95+23.75%
2022-02-25400+194+94.17%
2021-03-30206

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
AbCellera Biologics Inc.
ABCL
AbCellera Biologics Inc.YOU
562
#2
Nuvation Bio Inc.
NUVB
Nuvation Bio Inc.
273
#3
Biohaven Ltd.
BHVN
Biohaven Ltd.
256
#4
Celldex Therapeutics, Inc.
CLDX
Celldex Therapeutics, Inc.
186
#5
Immunome, Inc.
IMNM
Immunome, Inc.
131
#6
Pharvaris N.V.
PHVS
Pharvaris N.V.
108
#7
Janux Therapeutics, Inc.
JANX
Janux Therapeutics, Inc.
91
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ABCL peer comparison

About ABCL employees

ABCL Employees · Headcount

AbCellera Biologics Inc. (ABCL) employee data is sourced from the annual SEC 10-K filing. As of 2025, AbCellera Biologics Inc. had 562 full-time employees globally. Full-time employees only. Global consolidated headcount.

AbCellera Biologics Inc. employs 562 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $133,680, reflecting the company's operational efficiency.

AbCellera Biologics Inc.'s workforce decreased by 38 (6.33%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

AbCellera Biologics Inc.'s revenue per employee of $133,680 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

ABCL Employees · 5 questions

As of the latest SEC 10-K filing (2025), AbCellera Biologics Inc. had 562 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

AbCellera Biologics Inc. employee counthow many employees does AbCellera Biologics Inc. haveABCL total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-24